Literature DB >> 32312788

COVID-19 infection in Crohn's disease under treatment with adalimumab.

Antonio Tursi1, Gioacchino Angarano2, Laura Monno2, Annalisa Saracino2, Fabio Signorile2, Aurelia Ricciardi2, Alfredo Papa3.   

Abstract

Entities:  

Keywords:  crohn's disease; immune response

Mesh：

Substances：

Year:  2020        PMID： 32312788     DOI： 10.1136/gutjnl-2020-321240

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  18 in total

1.  Anti-TNF-α Agents in Inflammatory Bowel Disease and Course of COVID-19.

Authors:  Antonio Tursi; Lorenzo Maria Vetrone; Alfredo Papa
Journal:  Inflamm Bowel Dis       Date:  2020-06-18       Impact factor: 5.325

Review 2.  The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications.

Authors:  Franco Scaldaferri; Gianluca Ianiro; Giuseppe Privitera; Loris Riccardo Lopetuso; Lorenzo Maria Vetrone; Valentina Petito; Daniela Pugliese; Matteo Neri; Giovanni Cammarota; Yehuda Ringel; Guido Costamagna; Antonio Gasbarrini; Ivo Boskoski; Alessandro Armuzzi
Journal:  Inflamm Bowel Dis       Date:  2020-08-20       Impact factor: 5.325

3.  Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape.

Authors:  Alfredo Papa; Loris Riccardo Lopetuso; Antonio Tursi
Journal:  Clin Gastroenterol Hepatol       Date:  2020-08-18       Impact factor: 11.382

Review 4.  Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group.

Authors:  Serena Arrigo; Patrizia Alvisi; Claudia Banzato; Matteo Bramuzzo; Fortunata Civitelli; Antonio Corsello; Giulia D'Arcangelo; Anna Dilillo; Valeria Dipasquale; Enrico Felici; Maurizio Fuoti; Simona Gatti; Zeno Giusti; Daniela Knafelz; Paolo Lionetti; Federica Mario; Antonio Marseglia; Stefano Martelossi; Chiara Moretti; Lorenzo Norsa; Federica Nuti; Roberto Panceri; Stefania Rampado; Sara Renzo; Claudio Romano; Erminia Romeo; Caterina Strisciuglio; Massimo Martinelli
Journal:  Dig Liver Dis       Date:  2020-10-22       Impact factor: 4.088

5.  IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression.

Authors:  Sujan K Dhar; Vishnupriyan K; Sharat Damodar; Shashi Gujar; Manjula Das
Journal:  Heliyon       Date:  2021-01-29

Review 6.  The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?

Authors:  Dounia Darif; Ikram Hammi; Ayyoub Kihel; Imane El Idrissi Saik; Fadila Guessous; Khadija Akarid
Journal:  Microb Pathog       Date:  2021-02-18       Impact factor: 3.848

Review 7.  Receptor for advanced glycation end-products axis and coronavirus disease 2019 in inflammatory bowel diseases: A dangerous liaison?

Authors:  Armando Rojas; Iván Schneider; Cristian Lindner; Ileana Gonzàlez; Miguel Angel Morales
Journal:  World J Gastroenterol       Date:  2021-05-21       Impact factor: 5.742

8.  Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes?

Authors:  Abdullah Abdullah; Markus F Neurath; Raja Atreya
Journal:  Visc Med       Date:  2020-06-05

Review 9.  Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease.

Authors:  Alfredo Papa; Antonio Gasbarrini; Antonio Tursi
Journal:  Am J Gastroenterol       Date:  2020-10       Impact factor: 12.045

10.  2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases.

Authors:  Carlos Taxonera; Iñigo Sagastagoitia; Cristina Alba; Norberto Mañas; David Olivares; Enrique Rey
Journal:  Aliment Pharmacol Ther       Date:  2020-06-07       Impact factor: 9.524
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.